Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Viveca, Gyberg"'
Autor:
Sara Meziani, Giulia Ferrannini, Mette Bjerre, Troels K. Hansen, Viveca Ritsinger, Anna Norhammar, Viveca Gyberg, Per Näsman, Lars Rydén, Linda G. Mellbin
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-8 (2022)
Abstract Background Mannose binding lectin (MBL) has been suggested to be associated with an impaired cardiovascular prognosis in dysglycaemic conditions, but results are still contrasting. Our aims are (i) to examine whether MBL levels differ betwee
Externí odkaz:
https://doaj.org/article/d04363d403984f26a06009068c5b3b41
Autor:
Giulia Ferrannini, Dirk De Bacquer, Pieter Vynckier, Guy De Backer, Viveca Gyberg, Kornelia Kotseva, Linda Mellbin, Anna Norhammar, Jaakko Tuomilehto, David Wood, Lars Rydén, EUROASPIRE IV & V Investigators
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-12 (2021)
Abstract Background Gender disparities in the management of dysglycaemia, defined as either impaired glucose tolerance (IGT) or type 2 diabetes (T2DM), in coronary artery disease (CAD) patients are a medical challenge. Recent data from two nationwide
Externí odkaz:
https://doaj.org/article/0348029b0ef54ed2ab14d6064ea94aad
Autor:
Bahira Shahim, Viveca Gyberg, Dirk De Bacquer, Kornelia Kotseva, Guy De Backer, Oliver Schnell, Jaakko Tuomilehto, David Wood, Lars Rydén
Publikováno v:
Cardiovascular Diabetology, Vol 17, Iss 1, Pp 1-11 (2018)
Abstract Background Dysglycaemia defined as type 2 diabetes (T2DM) and impaired glucose tolerance (IGT), increases the risk of cardiovascular disease (CVD). The negative impact is more apparent in the presence of hypertension and/or dyslipidaemia. Th
Externí odkaz:
https://doaj.org/article/4ef53bf42233422cb0f0071118039834
Autor:
David R. Wood, Viveca Gyberg, Jaakko Tuomilehto, Linda Mellbin, Giulia Ferrannini, Lars Rydén, Pieter Vynckier, Dirk De Bacquer, Kornelia Kotseva, Anna Norhammar, Guy De Backer
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-12 (2021)
Cardiovascular Diabetology
CARDIOVASCULAR DIABETOLOGY
Cardiovascular Diabetology
CARDIOVASCULAR DIABETOLOGY
Background Gender disparities in the management of dysglycaemia, defined as either impaired glucose tolerance (IGT) or type 2 diabetes (T2DM), in coronary artery disease (CAD) patients are a medical challenge. Recent data from two nationwide cohorts
Autor:
Giulia Ferrannini, Dirk De Bacquer, Iris Erlund, Viveca Gyberg, Kornelia Kotseva, Linda Mellbin, Anna Norhammar, Oliver Schnell, Jaakko Tuomilehto, Terhi Vihervaara, David Wood, Lars Rydén
Publikováno v:
Diabetes care. 45(9)
Background The optimal screening strategy for dysglycaemia, including type 2 diabetes (T2DM) and impaired glucose tolerance (IGT), in patients with coronary artery disease (CAD) is debated. Purpose We tested the hypothesis that measures of insulin re
Publikováno v:
Diabetes Care. 43:2001-2009
Type 2 diabetes represents a major threat to global health mainly because of its strong link to atherosclerotic vascular disease. From position 15 among the 20 leading causes of loss of disability-adjusted life-years in 2000, type 2 diabetes climbed
Autor:
Giulia, Ferrannini, Dirk, De Bacquer, Viveca, Gyberg, Guy, De Backer, Kornelia, Kotseva, Linda G, Mellbin, Rebecca, Risebrink, Jaakko, Tuomilehto, David, Wood, Lars, Rydén
Publikováno v:
Diabetes research and clinical practice. 183
An oral glucose tolerance test (OGTT) combining fasting (FPG) and 2-hour plasma glucose (2hPG) is the most sensitive method for detecting type 2 diabetes (T2DM). Since it is considered time-consuming, we aim at validating a previously proposed screen
Autor:
Viveca Gyberg, Rebecca Risebrink, Linda Mellbin, David R. Wood, Jaakko Tuomilehto, Dirk De Bacquer, Lars Rydén, Giulia Ferrannini, Guy De Backer, Kornelia Kotseva
Publikováno v:
Diabetes Research and Clinical Practice. 183:109156
Aims An oral glucose tolerance test (OGTT) combining fasting (FPG) and 2-hour plasma glucose (2hPG) is the most sensitive method for detecting type 2 diabetes (T2DM). Since it is considered time-consuming, we aim at validating a previously proposed s
Autor:
Per Näsman, Viveca Gyberg, Anna Norhammar, Viveca Ritsinger, Maria Isabel Smaradottir, Linda Mellbin
Publikováno v:
Diabetes and Vascular Disease Research. 14:69-76
Objective: To characterize copeptin levels and to explore its prognostic importance in patients with acute myocardial infarction with newly detected glucose abnormalities. Methods: Copeptin was measured in 166 patients with acute myocardial infarctio
Autor:
Nana Pogosova, Dirk De Bacquer, Stefan Störk, Peter U. Heuschmann, Raphael Oganov, Andrzej Pajak, Mirza Dilic, Nina Gotcheva, Renata Cifkova, Delphine De Smedt, Andrejs Erglis, Dragan Lovic, Dan Gaita, Lale Tokgozoglu, Catriona Jennings, Lars Rydén, Philippe Amouyel, Bahira Shahim, Aleksandras Laucevičius, David R. Wood, Martin Stagmo, Guy De Backer, Martin Wagner, Evagoras Nicolaides, Kornelia Kotseva, Zeljko Reiner, Davor Miličić, Jan Bruthans, John A. Goudevenos, Almudena Castro Conde, Seppo Lehto, Viveca Gyberg, Johan De Sutter, David D. Moore, Jaap W. Deckers, Dusko Vulic, Maryna Dolzhenko, Zlatko Fras
Publikováno v:
European Journal of Epidemiology
Volume 34
Issue 3
European Journal of Epidemiology, 34(3), 247-258. Springer Netherlands
Volume 34
Issue 3
European Journal of Epidemiology, 34(3), 247-258. Springer Netherlands
The EUROASPIRE surveys (EUROpean Action on Secondary Prevention through Intervention to Reduce Events) demonstrated that most European coronary patients fail to achieve lifestyle, risk factor and therapeutic targets. Here we report on the 2-year inci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::895e04fb800ab38242406d300b613afb
https://ruj.uj.edu.pl/xmlui/handle/item/144580
https://ruj.uj.edu.pl/xmlui/handle/item/144580